Genmab A/S (NASDAQ:GMAB) Short Interest Down 11.4% in November
Genmab A/S (NASDAQ:GMAB – Get Free Report) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 2,020,000 shares, a decline of 11.4% from the November 15th total of 2,280,000 shares. Currently, 0.3% of the company’s shares are short sold. Based […]
More Stories
Stifel Nicolaus Forecasts Strong Price Appreciation for CyberArk Software (NASDAQ:CYBR) Stock
CyberArk Software (NASDAQ:CYBR – Get Free Report) had its price objective boosted by analysts at Stifel Nicolaus from $335.00 to...
Stifel Nicolaus Issues Positive Forecast for DigitalOcean (NYSE:DOCN) Stock Price
DigitalOcean (NYSE:DOCN – Get Free Report) had its target price raised by analysts at Stifel Nicolaus from $35.00 to $40.00...
News from the WHO: President Macron, WHO Director-General, and global health leaders inaugurate WHO Academy in Lyon https://ift.tt/IPbFCsE December 18, 2024 at 07:00AM
Published on December 18, 2024 at 07:00AM View on website
Acupuncture Proven Effective for Sciatica: Clinical Trial
By Jessica Lee Sciatica is a notoriously difficult condition to treat, with limited success from both conservative therapies and surgical...
Fastly (NYSE:FSLY) Shares Gap Up – Still a Buy?
Fastly, Inc. (NYSE:FSLY – Get Free Report)’s share price gapped up before the market opened on Wednesday . The stock...
Unum Group (NYSE:UNM) Given New $82.00 Price Target at Piper Sandler
Unum Group (NYSE:UNM – Get Free Report) had its target price boosted by analysts at Piper Sandler from $74.00 to...